---
title: "U.S. stock night trading opened with fluctuations: Wheels Up Experience rose 18.27% in night trading; Sky Quarry rose 14.73% in night trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272765751.md"
description: "Wheels Up Experience rose 18.27% in after-hours trading; Sky Quarry rose 14.73% in after-hours trading; ImmunityBio rose 31.39% in after-hours trading; Freedom Global-B rose 27.22% in after-hours trading; Brand Engagement Network rose 14.19% in after-hours trading"
datetime: "2026-01-16T01:06:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272765751.md)
  - [en](https://longbridge.com/en/news/272765751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272765751.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/272765751.md) | [繁體中文](https://longbridge.com/zh-HK/news/272765751.md)


# U.S. stock night trading opened with fluctuations: Wheels Up Experience rose 18.27% in night trading; Sky Quarry rose 14.73% in night trading

**U.S. Stock Night Market Opening Movements**

Wheels Up Experience, up 18.27% in the night market, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Sky Quarry, up 14.73% in the night market, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in the U.S. Night Market**

ImmunityBio, up 31.39% in the night market. Based on recent key news:

1.  On January 14, ImmunityBio received accelerated approval from the Saudi Food and Drug Authority for its Anktiva treatment regimen for metastatic non-small cell lung cancer and non-muscle invasive bladder cancer. This approval drove the stock price up, showing market confidence in its treatment regimen. Source: Reuters
    
2.  On January 15, ImmunityBio announced its fourth-quarter net product revenue reached approximately $38.3 million, a year-on-year increase of about 431%. This financial performance boosted investor confidence, further driving the stock price up. Source: Business Wire
    
3.  On January 16, Benzinga Edge signals indicated strong momentum for ImmunityBio's stock, with increased investor interest in holding or entering the market, leading to continued stock price increases. Source: Benzinga The biotechnology sector has recently performed strongly, with significant capital inflows.
    

Freedom Global-B, up 27.22% in the night market, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Brand Engagement Network, up 14.19% in the night market, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [Wheels Up Experience Inc. (UP.US)](https://longbridge.com/en/quote/UP.US.md)
- [Sky Quarry Inc. (SKYQ.US)](https://longbridge.com/en/quote/SKYQ.US.md)

## Related News & Research

- [Sky Quarry Inc. Issues Clarification Regarding New CUSIP Following 1-for-8 Reverse Stock Split | SKYQ Stock News](https://longbridge.com/en/news/279022221.md)
- [Sky Quarry Inc. Announces 1-for-8 Reverse Stock Split | SKYQ Stock News](https://longbridge.com/en/news/277991456.md)
- [IJT Plays Small-Cap Growth With Guardrails, ISCG Goes All In](https://longbridge.com/en/news/278939844.md)
- [Fund review: Kotak Small Cap Fund](https://longbridge.com/en/news/278857985.md)
- [Consumer Sentiment Falls as Iran War Worries Weigh](https://longbridge.com/en/news/279071960.md)